US Defense Lab Selects Third Wave Reagents for CF Screening | GenomeWeb

NEW YORK, Dec 9 (GenomeWeb News) - The US Armed Forces Institute of Pathology (AFIP) - the central reference laboratory for the Army, Navy, Air Force, Public Health Service, and Department of Veterans Affairs - has selected Third Wave Technologies' Invader analyte-specific reagents for cystic fibrosis (CF) genetic screening, the company said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.